Clinical Trial: Study of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants.

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885202) titled 'Study of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants.' on Oct. 09.

Brief Summary: This is a single-center, randomized, double-blind, placebo-controlled, single ascending-dose study designed to evaluate the safety, tolerability, and pharmacokinetic characteristics of VV147 tablets in healthy participants.

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: VV147 15mg Group

6 participants receive VV147 15mg,orally; 2 participants will receive placebo,orally

DRUG: VV147 30mg Group

6 participants receive VV147 30mg,orally; 2 par...